Management

Highly experienced and successful team of industry experts
Ahmad Doroudian, PhD

Ahmad Doroudian, PhD

Chief Executive Officer

  • 20+ years experience as a Pharma CEO in finance, including M&A, and multiple IPOs, Integration of pharmaceutical operations (Whitehall Robbins, Rhone Polenc, Boehringer, Aventis)
  • Founder of Merus Labs (NASDAQ: MSLI), sold for $300 M+ in 2017
  • Acquisition, integration, tech transfer and management of branded pharmaceutical products Enablex®/Emselex®, Entrophen®, Sandomigran®, Sintrom®, Vancocin®, Zaditen®

 

Hooshmand Sheshbaradaran, PhD

Hooshmand Sheshbaradaran, PhD

Chief Operating Officer

  • 30+ years senior pharma executive with experience in global drug development, marketing, business strategy, operations, licensing and M&A
  • Senior executive roles at Pharmacia/Pfizer, Roche, Zeneus/Cephalon, Niiki Pharma, Psioxus
  • Development of Camptosar®, Ellence®, Emcyt®, Sutent® and Vidaza®.

               

Angela Ogden, MD

Angela Ogden, MD

Chief Medical Officer

  • 25+ year senior executive-level experience developing therapeutics from preclinical to launch including several blockbusters; plus 10+ years senior level academic medicine experience.
  • Senior executive roles at Pharmacia/Pfizer, BMS, JNJ, BTG
  • Development of Abraxane®, Aromasin®, Celebrex®, Dacogen®, Erbitux®, Folotyn®, TheraSphere®, Varithena®, Velcade®

                

Scott Rudge, PhD

Scott Rudge, PhD

CMC Head

  • Founded CMC development expert services group in 2004, has worked on over 200 projects for all molecule/therapy classes since
  • Site Director & VP Operations for FeRx; increasing management responsibility at NIST, Synergen, Amylin
  • PhD in Chemical Engineering from Purdue and author of multiple peer reviewed articles, book chapters and an award-winning textbook

NIST logo          Synergen logo             Amylin Pharma logo

Jeff Fellows

Jeff Fellows

Head of Regulatory

  • 30+ years of drug development experience leading regulatory development efforts
  • Worked with early stage development companies and a large multinational biopharmaceutical enterprise developing programs across numerous therapeutic areas
  • Previously VP of Regulatory Affairs at Cell Therapeutics (currently CTI BioPharma, NASDAQ and MTA: CTIC), held senior positions in Regulatory Affairs at Amgen

CTI logo           Amgen logo

Joseph Lamendola, PhD

Joseph Lamendola, PhD

Regulatory Strategy Advisor

  • 30+ years senior executive-level experience in pharma global regulatory from pre-IND to NDA
  • Executive roles at Schering Plough / Merck; BMS; Biopharmaceutical Practice
  • Filed and approved near 30 NDAs in ten different therapeutic areas

                

Dawn East, RN, BSN, OCN

Dawn East, RN, BSN, OCN

Head Clinical Operations

  • 30+ years experience of clinical operations
  • Held senior clinical operations positions at inVentiv Health, INC Research & Quintiles

inVentiv Health logo             INC Research logo Quintiles logo

Moira Ong, CPA

Moira Ong, CPA

Chief Financial Officer

  • 18+ years experience as VP of Finance & CFO in several private and public companies including Merus Labs (NASDAQ: MSLI), and BetterLife Pharma (CNSX: BETR; formerly Pivot Pharmaceuticals)
  • Managed the integration of the supply chain management and accounting Vancocin, Enablex®/Emselex®, acquired from Novartis, by Merus Labs International Inc.
  • Previously at Grant Thornton and Deloitte

                              BetterLife Pharma logo